The latest closing stock price for Blueprint Medicines as of June 26, 2025 is 128.15.
An investor who bought $1,000 worth of Blueprint Medicines stock at the IPO in 2015 would have $5,791 today, roughly 6 times their original investment - a 21.11% compound annual growth rate over 10 years.
The all-time high Blueprint Medicines stock closing price was 128.40 on June 23, 2025.
The Blueprint Medicines 52-week high stock price is 128.45, which is 0.2% above the current share price.
The Blueprint Medicines 52-week low stock price is 73.04, which is 43% below the current share price.
The average Blueprint Medicines stock price for the last 52 weeks is 97.85.
An investor who bought $1,000 worth of Blueprint Medicines stock at the IPO in 2015 would have $5,791 today, roughly 6 times their original investment - a 21.11% compound annual growth rate over 10 years.
The all-time high Blueprint Medicines stock closing price was 128.40 on June 23, 2025.
The Blueprint Medicines 52-week high stock price is 128.45, which is 0.2% above the current share price.
The Blueprint Medicines 52-week low stock price is 73.04, which is 43% below the current share price.
The average Blueprint Medicines stock price for the last 52 weeks is 97.85.